Tilting Offshore Windmills: Speaking Truth to Ratepayers

Share on Facebook
Share on Twitter
Share on
LinkedIn
+

Joe Selvaggi talks with energy economist Dr. Jonathan Lesser about the chasm between the promises and realities of offshore wind projects, including the likely increased costs passed to electricity consumers and taxpayers.

Guest:

Jonathan Lesser is an adjunct fellow at the Manhattan Institute. As president of Continental Economics, Lesser has more than 30 years of experience working for regulated utilities, for government, and as a consultant in the energy industry. He has addressed economic and regulatory issues affecting energy in the U.S., Canada, and Latin America. Those issues include gas and electric utility structure and operations, generating asset valuation under uncertainty, cost-benefit analysis, mergers and acquisitions, cost allocation and rate design, resource investment-decision strategies, cost of capital, depreciation, risk management, incentive regulation, economic impact studies, and energy and environmental policies.

WATCH:

Recent Episodes

The Oldest Hatred: Calling Out Antisemitism In Its Many Forms

Hubwonk host Joe Selvaggi talks with Boston Globe opinion writer Jeff Jacoby about the troubling increase in antisemitic incidents, including the recent attack on a Boston rabbi, and how our current political rancor fans the flames of bigotry nationwide.

Court Preserves Privacy: First Amendment Ruling Defends Non-Profits From Modern-Day McCarthyism

Hubwonk Host Joe Selvaggi talks with CATO research fellow and constitutional scholar Trevor Burrus about the recent Supreme Court ruling, Americans For Prosperity Foundation v. Bonta, reaffirming the right to privacy by denying the state of California the right to compel non-profits to disclose their list of donors.

Renters’ Unsung Heroes: Small Landlords Endure Without Income or Relief

Hubwonk host Joe Selvaggi talks with MassLandlords’ Doug Quattrochi about ways landlords faced the challenges of being caught between tenants unable to pay rent during COVID-19 shutdown and having little or no programmatic relief from state and federal agencies.

Alzheimer Breakthrough Disillusionment: Confusion on FDA’s Approval of Expensive and Possibly Ineffective Drug

Hubwonk host Joe Selvaggi talks with precision medicine expert Hannah Mamuszka and Pioneer Institute's Bill Smith about the promises and pitfalls of the newly approved Alzheimer’s drug Aduhelm, and the challenges presented when new, expensive drugs of dubious benefit are introduced to the nation’s formulary.